Skip to Main Content
Our Commitment to Diversity
Stephen D. Bittinger

Stephen Bittinger is a partner and a member of the Health Care/FDA practice group. Stephen focuses his practice on health care reimbursement compliance, defense and litigation, with an emphasis on government and private payer disputes on behalf of providers, suppliers, and manufacturers involved in the US health care system nationally and from abroad. He has extensive experience representing large provider groups, home health agencies, medical facilities, ancillary service providers, medical labs, revenue cycle management companies, and drug and device manufacturers in matters including Medicare and Medicaid audits, private payer audits, federal regulatory termination and exclusion proceedings, False Claims Act defense, and health care revenue disputes. Stephen is one of the leading attorneys in the country on the law regarding the use of statistical sampling and extrapolation in the review and analysis of health care claims. He has served as an expert witness regarding federal reimbursement law in civil and criminal proceedings. Stephen has represented many providers with federal agency matters, including the Centers for Medicare and Medicaid Services (CMS) Center for Program Integrity (CPI), the Department of Health and Human Services Office of Inspector General (HHS-OIG), the Department of Veteran Affairs (VA), and Health Care Fraud division of the Department of Justice (DOJ).

Prior to joining the firm Stephen served at a regional commercial law firm where he focused his practice on health care reimbursement defense and litigation. Previously, Stephen and team represented numerous types of physician practices, home health agencies, medical facilities, ancillary service providers, medical laboratories, revenue cycle management companies, and drug/device manufacturers in Medicare audits (RAC, ZPIC, UPIC, TPE), Medicaid audits (SIU), private payors audits, federal regulatory termination, and exclusion litigation related to the health care revenue cycle.

  • Presenter, “The Physician in the Legal Ecosystem,” Medical University of South Carolina, College of Medicine, 22 April 2024
  • Presenter, “OIG, FCA, & RADV: The Rising Risk of Medicare Advantage,” Cozeva, 18 October 2023
  • Panelist, “Hunting Health Care Fraud Post-Pandemic: Audits and Investigations,” Charleston Health Care Summit, 13 October 2023
  • Panelist, "Hunting Pandemic Fraud: Audits and FCA Litigation Resulting
    From the PHE
    ," 2023 Physicians Legal Issues: Healthcare Delivery & Innovation Conference, 7 September 2023
  • Panelist, "The Current State of RA Litigation and Risk Areas for MA Plans, Physician Groups, Vendors and Downstream Entities," RISE West 2023, 29 August 2023
  • Panelist, "Legal Challenges to Extrapolated Overpayments from RADV Audits," Rise 21st Risk Adjustment Forum, 10 May 2023
  • Presenter, Risk Adjustment Innovations, "Staying Compliant as Regulatory Activity Increases for Risk Adjustment: CMS RADV Regulations, OIG Audits, and DOJ Lawsuits," 18 April 2023
  • Speaker, MedtradeEAST, "Understanding How the Government Uses Audits to Bring Fraud Investigations," 24 October 2022
  • Speaker, Homecare and Hospice Conference and Expo, "Legal Challenges to Statistical Sampling & Extrapolated Overpayments," October 2022 
  • Speaker, RISE West 2022, "The Current State of RA Litigation and Risk Areas for MA Plans, Vendors and Downstream Entities," 1 September 2022
  • Speaker, Risk Adjustment Compliance – Best Practices For Avoiding Legal Action, 9 November 2021
  • Speaker, RISE West 2021, "Legal Insights Panel: Trends in Audit and Compliance Issues," 2 September 2021
  • Speaker, Virtual Regional Healthcare Compliance Conference: "Big Data and False Claims Act Risk Due to COVID-19," Health Care Compliance Association, 6 August 2021
Additional Thought Leadership Pages
Additional News & Event Pages
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel